Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Intuitive Surgical
(NQ:
ISRG
)
469.31
-0.68 (-0.14%)
Streaming Delayed Price
Updated: 3:45 PM EDT, Mar 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intuitive Surgical
< Previous
1
2
3
4
5
6
7
8
9
...
58
59
Next >
2 Top Healthcare Stocks to Buy in February
↗
February 07, 2026
There's a bright future ahead for both, but it's important to be patient.
Via
The Motley Fool
Topics
World Trade
Why This Stock's January Slump Could Be a Gift for Patient Investors
↗
February 07, 2026
Intuitive Surgical's stock is prone to drawdowns, and January could be an opening for long-term growth investors.
Via
The Motley Fool
Topics
Artificial Intelligence
"Rule Breaker Investing" Mailbag: Values, Kids, Games, and Inspiration
↗
February 06, 2026
This "Rule Breaker Investing" mailbag brings together beautiful questions and stories to start the new year.
Via
The Motley Fool
Robocap Offloads 35,000 NICE Shares Worth $5.1 Million, According to Recent SEC Filing
↗
February 02, 2026
NICE delivers AI-driven cloud platforms for enterprises, focusing on digital business, compliance, and fraud prevention solutions.
Via
The Motley Fool
Topics
Artificial Intelligence
Fraud
Regulatory Compliance
2 S&P 500 Stocks to Research Further and 1 Facing Challenges
February 01, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...
Via
StockStory
Topics
Stocks
Should You Buy Shares of Intuitive Surgical In February?
↗
January 31, 2026
Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for investors.
Via
The Motley Fool
Topics
Artificial Intelligence
1 No-Brainer Stock to Buy on the Dip
↗
January 31, 2026
Patient investors who ride out the storm could be rewarded down the road.
Via
The Motley Fool
Topics
Government
2 AI Surgery Stocks to Buy Hand Over Fist in February
↗
January 30, 2026
Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the heart of it.
Via
The Motley Fool
Topics
Artificial Intelligence
Calculating Risk Foolishly, Vol. 4: ETSY vs. DUOL
↗
January 30, 2026
Risk gets talked about a lot in investing -- and often defined poorly.
Via
The Motley Fool
5 Revealing Analyst Questions From Intuitive Surgical’s Q4 Earnings Call
January 29, 2026
Intuitive Surgical’s fourth quarter saw results above Wall Street’s expectations, driven by increased global procedure volumes and demand for the new da Vinci 5 system. Management highlighted continued...
Via
StockStory
Topics
Earnings
World Trade
NHS Launches Pioneering “Ultra-Early” Lung Cancer AI Trials to Save Thousands of Lives
January 28, 2026
The National Health Service (NHS) in England has officially entered a new era of oncology with the launch of a revolutionary "ultra-early" lung cancer detection trial. Integrating advanced artificial...
Via
TokenRing AI
Topics
Artificial Intelligence
The $100 Billion Milestone: Johnson & Johnson Pivots from 'Steady' 2025 to Growth-Focused 2026
January 27, 2026
NEW BRUNSWICK, N.J. — Johnson & Johnson (NYSE: JNJ) has officially closed the chapter on a year many analysts described as "transitional," reporting full-year 2025 earnings that met expectations while...
Via
MarketMinute
Topics
Earnings
Economy
Government
Forget Tech Stocks: The Medical Device Maker That's Essential to AI Healthcare
↗
January 27, 2026
This company's surgical robots already use AI, and the future could be even more exciting.
Via
The Motley Fool
Topics
Artificial Intelligence
Da Vinci 5 Cleared for Cardiac Procedures
January 26, 2026
FDA 510(k) clearance expands da Vinci 5 indications to include certain cardiac procedures
From
Intuitive Surgical, Inc.
Via
GlobeNewswire
2 Growth Stocks to Stash and 1 We Question
January 25, 2026
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Via
StockStory
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors
↗
January 25, 2026
Via
MarketBeat
3 Troubling Trends for Intuitive Surgical – and 1 Bright Spot
↗
January 24, 2026
This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.
Via
The Motley Fool
Topics
Earnings
Supply Chain
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term.
↗
January 23, 2026
Artificial intelligence may be all the rage in the technology sector, but it's also having a huge impact on healthcare.
Via
The Motley Fool
Topics
Artificial Intelligence
Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles
January 23, 2026
Following a resilient performance throughout 2025, healthcare giant Johnson & Johnson (NYSE: JNJ) has officially set its sights on a historic milestone for 2026. In its latest earnings report released...
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
Intuitive Surgical Just Proved the Growth Engine Still Runs
↗
January 23, 2026
Via
MarketBeat
Intuitive Surgical Tops Expectations as Robotic Surgeries See Massive Surge
↗
January 23, 2026
Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and $2.53 EPS.
Via
Benzinga
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
January 23, 2026
As of January 23, 2026, Johnson & Johnson (NYSE:JNJ) finds itself at a historic crossroads. After spending much of 2025 navigating the "patent cliff" of its blockbuster drug Stelara and finalizing its...
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
ISRG Q4 Deep Dive: New Product Launches and International Growth Drive Results
January 23, 2026
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 18.8% year on year to $2.87 billion. Its non-GAAP profit of...
Via
StockStory
Topics
World Trade
20 Million Patients Benefit from da Vinci Surgery Globally
January 23, 2026
Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive’s minimally invasive technologies
From
Intuitive Surgical, Inc.
Via
GlobeNewswire
Which S&P500 stocks are moving before the opening bell on Friday?
↗
January 23, 2026
Via
Chartmill
This Often-Overlooked Growth Stock Just Reported An Amazing Quarter. Time to Buy Shares?
↗
January 22, 2026
This robotics company just put up another quarter of amazing growth, and the reasons to love the stock keep adding up.
Via
The Motley Fool
Intuitive Surgical (ISRG) Earnings Transcript
↗
January 22, 2026
Intuitive Surgical (ISRG) Earnings Transcript
Via
The Motley Fool
Topics
World Trade
Intuitive Surgical Stock Climbs After Company Tops Q4 Earnings
↗
January 22, 2026
Intuitive Surgical Inc (NASDAQ:ISRG) reports financial results for the fourth quarter on Thursday. Here's a rundown of the report.
Via
Benzinga
Intuitive Surgical (NASDAQ:ISRG) Delivers Impressive Q4 CY2025
January 22, 2026
Medical technology company Intuitive Surgical (NASDAQ:ISRG) announced better-than-expected revenue in Q4 CY2025, with sales up 18.8% year on year to $2.87 billion. Its non-GAAP profit of $2.53 per...
Via
StockStory
Intuitive Announces Fourth Quarter Earnings
January 22, 2026
From
Intuitive Surgical, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
58
59
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.